Latest Cadence Pharmaceuticals Inc. Stories

2014-02-28 16:23:53

SAN DIEGO, Feb. 28, 2014 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the three and twelve months ended December 31, 2013. Recent highlights included: -- Cadence entered into an agreement and plan of merger agreement with Mallinckrodt plc and one of its wholly owned...

2014-02-11 16:25:57

SAN DIEGO, Feb. 11, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) by Mallinckrodt plc (NYSE: MNK). On February 11, 2014, the two companies announced the signing of a definitive agreement pursuant to which a subsidiary of Mallinckrodt will commence a tender offer to acquire all outstanding shares of Cadence stock for $14.00 per share in cash. (Logo:...

2014-02-11 12:26:40

NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Cadence Pharmaceuticals, Inc. ("Cadence Pharmaceuticals" or the "Company") (NASDAQ: CADX) breached its fiduciary duty to its shareholders in agreeing to sell Cadence Pharmaceuticals to Mallinckrodt plc. (Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO) Under the terms of the agreement, Cadence Pharmaceuticals shareholders will receive $14.00 in cash for...

Word of the Day
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.